Der Urologe. Ausg. A
-
Der Urologe. Ausg. A · Apr 2021
[Virtual skills-training in urology : Teaching at the Technical University of Munich during the COVID-19-pandemic].
The COVID-19 pandemic presents the challenge for medical education to teach practical skills without practical training. To provide an alternative to hands-on training during the COVID-19 lockdown, we created a virtual curriculum to teach practical skills using videos combined with online exams on a virtual e‑learning platform. The goal was to convey different theoretical and practical aspects of urology. ⋯ The virtual curriculum offered a fast and contactless alternative to the regular hands-on teaching.
-
The coronavirus pandemic is a major challenge for healthcare systems worldwide. For urology, the expansion of the health-care structures for the treatment of patients suffering from COVID-19 should be supported as best as possible. At the same time, one should aim to ensure adequate care for urological emergencies and urgent urological treatments as far as possible, even during the pandemic. ⋯ Urological clinics must prepare themselves to perform urgent operations and interventions on SARS-CoV‑2-positive patients. Here, the creation of a separate, appropriately equipped emergency operating room to perform operations and interventions on SARS-CoV‑2 patients should be considered. Furthermore strictly defined hygiene measures to protect employees in various clinical scenarios should be set up.
-
Der Urologe. Ausg. A · Mar 2020
Review[Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group].
Technical advancement and availability of high-throughput analysis has advanced molecular subtyping of most cancers. Thus, new possibilities for precision oncology have emerged. ⋯ So far, despite availability of NGS diagnostics at university institutes of pathology, only few bladder cancer samples have been sequenced. Based on current data from the molecular subtyping of bladder cancers, we recommend a step-by-step protocol with basic immunohistochemistry analysis and subsequent subtype-dependent analyses, e.g., alterations of the fibroblast growth factor receptors (FGFR) or comprehensive gene panel analyses.